Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
To cite this article: Valero A, Ferrer M, Baró E, Sastre J, Navarro AM, Martí‐Guadaño E, Dávila I, del Cuvillo A, Colás C, Antépara I, Alonso J, Mola O, Izquierdo I, Mullol J. Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis. Allergy 2010; 65: 1609–1613. Background: Allergic rhinitis (AR) is a common disease with major socioeconomic burden and a significant impact on quality of life. Objective: The aim of this study was to discriminate between moderate and severe AR patients whether receiving treatment or not, using a modified criterion of allergic rhinitis and its impact on asthma (ARIA) classification. Methods: The modified ARIA severity classification (J Allergy Clin Immunol, 120, 2007, 359) categorizes AR as mild (no items affected), moderate (1–3 items affected), and severe (all four items affected). We applied these criteria to 1666 treated and 1058 untreated AR patients and compared their symptoms total four‐symptom score (T4SS) and quality of life (ESPRINT‐15), according to their clinical severity. Results: Allergic rhinitis clinical status was significantly worse (P < 0.001) in treated than in untreated patients. For both treated and untreated patients, T4SS and ESPRINT‐15 Quality of life scores were significantly worse (P < 0.001) in severe than in moderate patients. Conclusions: The modified ARIA severity classification is a useful clinical tool to discriminate moderate from severe AR among both treated and untreated patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Severity and impairment of allergic rhinitis in patients consulting in primary care
Bousquet, J., Neukirch, F., Bousquet, P. J., Gehano, P., Klossek, J. M., Le Gal, M., & Allaf, B. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.047 · Cited by 298 · cited 4×
“However, as most AR patients attended in outpatient clinics are already treated (10, 11), recent studies have started to use the ARIA severity classification also in treated AR patients (2, 8, 12, 13).”
BackgroundInfluentialA survey of the burden of allergic rhinitis in the USA
Schatz, M. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01548.x · Cited by 223
Valero, A., Alonso, J., Antépara, I., Baró, E., Colás, C., Del Cuvillo, A., Ferrer, M., Herdman, M., Marti‐Guadaño, E., Monclús, L., et al. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01552.x · Cited by 54
Self-citation
Cited by
Impact of Allergic Rhinitis Symptoms on Quality of Life in Primary Care
Bousquet, P. J., Demoly, P., Devillier, P., Mesbah, K., & Bousquet, J. (2013) · International Archives of Allergy and Immunology · doi:10.1159/000342991 · Cited by 204
Impact of Sleep as a Specific Marker of Quality of Life in Allergic Rhinitis
González-Núñez, V., Valero, A. L., & Mullol, J. (2013) · Current Allergy and Asthma Reports · doi:10.1007/s11882-012-0330-z · Cited by 43
Self-citationThe classification of allergic rhinitis and its cytological correlate: ALLERGYNet
Gelardi, M., Incorvaia, C., Passalacqua, G., Quaranta, N., & Frati, F. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02741.x · Cited by 40
(2013) · PubMed · Cited by 20
Metadata
- Authors
- Valero, A., Ferrer, M., Baró, E., Sastre, J., Navarro, A. M., Martí‐Guadaño, E., Dávila, I., Del Cuvillo, A., Colás, C., Antépara, I., Alonso, J., Mola, O., Izquierdo, I., & Mullol, J.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2010-10-29
- Volume
- 65
- Issue
- 12
- Pages
- 1609-1613
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W1956021928
- Cited by
- 35
- References
- 3
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis. https://app.cochat.ai/papers/10.1111/j.1398-9995.2010.02410.x
- The paper
- Valero, A., Ferrer, M., Baró, E., Sastre, J., Navarro, A. M., Martí‐Guadaño, E., Dávila, I., Del Cuvillo, A., Colás, C., Antépara, I., Alonso, J., Mola, O., Izquierdo, I., & Mullol, J. (2010). Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis. Allergy. https://doi.org/10.1111/j.1398-9995.2010.02410.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.